Weibin Shi Selected Research

reticulocalbin

1/2022	Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis.
1/2019	Loss of reticulocalbin 2 lowers blood pressure and restrains ANG II-induced hypertension in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weibin Shi Research Topics

Disease

38	Atherosclerosis 06/2022 - 04/2002
10	Neoplasms (Cancer) 11/2021 - 01/2002
7	Hypertension (High Blood Pressure) 01/2022 - 06/2008
7	Body Weight (Weight, Body) 01/2020 - 03/2006
6	Hyperlipidemias (Hyperlipidemia) 01/2021 - 04/2004
5	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2015
5	Hyperglycemia 06/2022 - 05/2006
4	Inflammation (Inflammations) 01/2022 - 08/2007
4	Carotid Artery Diseases 01/2022 - 01/2008
3	Insulin Resistance 06/2022 - 12/2011
3	Pain (Aches) 11/2021 - 01/2019
3	Gallbladder Neoplasms (Gallbladder Cancer) 09/2021 - 09/2016
2	Obesity 06/2022 - 02/2015
2	Dyslipidemias (Dyslipidemia) 05/2022 - 11/2015
2	Diabetes Mellitus 01/2022 - 10/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2016
2	Low Back Pain (Lumbago) 01/2021 - 09/2020
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 04/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2013
2	Essential Hypertension 01/2016 - 05/2009
2	Glucose Intolerance 04/2015 - 03/2012
2	Acute-Phase Reaction 03/2012 - 05/2006
1	Hypercholesterolemia 06/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Rupture 01/2022
1	Stroke (Strokes) 01/2022
1	Ischemic Stroke 01/2022
1	Necrosis 12/2021
1	Hidradenitis Suppurativa 01/2019
1	Abscess 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hemorrhagic Shock 03/2018
1	Hemorrhage 03/2018
1	Hemothorax 03/2018
1	Pathologic Constriction (Stenosis) 01/2018
1	Renal Artery Obstruction (Renal Artery Stenosis) 06/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Carcinogenesis 09/2016

Drug/Important Bio-Agent (IBA)

30	Apolipoproteins E (ApoE)IBA 06/2022 - 04/2002
23	ApolipoproteinsIBA 01/2021 - 04/2002
10	LipidsIBA 05/2022 - 04/2002
9	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 05/2006
6	Insulin (Novolin)FDA Link 01/2016 - 05/2006
6	oxidized low density lipoproteinIBA 11/2008 - 04/2002
6	CholesterolIBA 11/2008 - 03/2006
6	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2008 - 04/2005
5	Triglycerides (Triacylglycerol)IBA 04/2020 - 03/2006
4	Lipoproteins (Lipoprotein)IBA 01/2022 - 06/2004
3	Circular RNAIBA 11/2021 - 07/2021
3	LDL CholesterolIBA 04/2020 - 04/2004
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2019 - 04/2002
3	Dopamine Receptors (Dopamine Receptor)IBA 10/2018 - 06/2008
3	Oxidants (Oxidizing Agents)IBA 10/2010 - 11/2006
3	LDL Receptors (LDL Receptor)IBA 07/2006 - 07/2002
2	reticulocalbinIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2021
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 04/2015
2	Malondialdehyde (Propanedial)IBA 04/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 09/2016 - 01/2013
2	Hormones (Hormone)IBA 01/2016 - 05/2009
2	Amyloid (Amyloid Fibrils)IBA 03/2012 - 05/2006
2	P-SelectinIBA 11/2008 - 04/2005
2	VLDL CholesterolIBA 11/2008 - 03/2006
2	Apolipoproteins B (ApoB)IBA 06/2004 - 04/2002
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022
1	SaltsIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Nanoparticle Drug Delivery SystemIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	CateninsIBA 09/2021
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2020
1	low density lipoprotein triglycerideIBA 01/2020
1	Type A Botulinum Toxins (Botox)FDA Link 01/2019
1	ORALIT (ORS)IBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 10/2018
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 10/2018
1	SodiumIBA 10/2018
1	MicellesIBA 11/2017
1	Long Noncoding RNAIBA 11/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	hypericinIBA 01/2017
1	gamma-GlutamylcyclotransferaseIBA 12/2016
1	Biological ProductsIBA 12/2016
1	Docetaxel (Taxotere)FDA Link 09/2016

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2016
2	Stents 03/2018 - 01/2018
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2021
1	Radiofrequency Ablation 11/2021
1	Denervation 01/2021
1	Ligation 01/2021
1	Aquatic Therapy 01/2019
1	Intraperitoneal Injections 10/2018
1	Percutaneous Coronary Intervention 03/2018
1	Catheters 06/2017